Adrenocortical carcinoma with tumour thrombus extension to right atrium: a rare finding in uncommon tumour
Sachin Patil, Vishwajeet Singh, Amit Kumar, Satya Narayan Sankhwar
Department of Urology, King George Medical University, Lucknow, Uttar Pradesh, India
Correspondence to Dr Sachin Patil, drsachin.uro@gmail.com
DESCRIPTION
A 30-year-old woman presented with a dull aching pain in the right hypochondrium for 2 years with a history of loss of weight and loss of appetite for 4 months. Clinical examination did not reveal any significant findings. An abdominal ultrasonography revealed a large mass (10.8 cm) arising from the adrenal gland. Further evaluation with a contrast- enhanced CT scan showed a well-defined heteroge- neously enhancing soft tissue attenuation lesion measuring 12.7x13.3×13.4 cm in the right adrenal gland (figures 1-3) with tumoural thrombosis in the inferior vena cava (IVC; figure 4) extending to the right atrium (figure 5). A whole-body scintigraphy was negative for bone metastases. Plasma levels of cortisol, aldosterone, 17-OH-progesterone, dehy- droepiandrosterone sulfate and 84-androstenedione were normal. A fine-needle aspiration cytology of mass showed findings consistent with adrenocortical carcinoma (ACC; figures 5 and 6). She was advised complete excision of ACC with tumour thrombec- tomy using cardiopulmonary bypass, but the patient refused surgery. She was given mitotane with three cycles of palliative chemotherapy using cyclophos- phamide, doxorubicin and cisplatin. The follow-up after completion of chemotherapy showed partial response with non-progressive tumour thrombus.
Philips Brilliance 64
P
360
1
11:26:57.2
80340-13 150.56 mm
R
10 cm
1
c1 W 1
101
0
Philips Brilliance 64
P
360
1929: 49.2
10
iance 64
ACC is a rare malignancy with incidence of 0.5- 2 cases/million/year.1 In ACC, the presence of IVC and atrial invasion is considered as tumour exten- sion and not as a metastatic disease. In such cases, a more aggressive surgical approach may give better results.2 For patients who are unfit for surgery or who refuse radical surgery, chemotherapy can be tried. To date, mitotane has been the only drug that has proven effective in treating patients with meta- static ACC.2 The combination of cisplatin, doxo- rubicin, etoposide and mitotane has produced clinical response rates of about 50% even in advanced cases.3
To cite: Patil S, Singh V, Kumar A, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2013- 200804
1
2013 11:29: 49.2
In
20
c1
z
Brilliance 64 F
20 Jun 2013 11:29: 09.2
80548-40
170.88 mm
C
R
5
c1
0
27
Learning points
Adrenocortical cancer is a very rare tumour with a poor prognosis.
Inferior vena cava (IVC) thrombus in adrenocortical carcinoma is rare and tumour extension up to the right atrium is an extremely rare finding.
Surgical extirpation is the only curative treatment for large adrenal masses with thrombus extending into the IVC/atrium.
In patients with advanced adrenocortical carcinoma, mitotane is a useful drug. The patients who do not afford mitotane or who do not tolerate mitotane, other chemotherapeutic agents such as cyclophosphamide, doxorubicin and cisplatin can be tried.
1:29:09.2
80548-4
13.14 mm
C
F
m
c1
84
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1 Meniconi RL, Caronna R, Schiratti M, et al. Adrenocortical carcinoma extending into the inferior vena cava in a patient with right kidney agenesis: surgical approach and review of literature. Int J Surg Case Rep 2012;3:302-4.
2 Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma. Cancer 88:711-36.
3 Kirschner LS. Paradigms for adrenal cancer: think globally, act locally. J Clin Endocrincol Metab 2006;91:4250-2.
Copyright 2013 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit http://group.bmj.com/group/rights-licensing/permissions. BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.
Become a Fellow of BMJ Case Reports today and you can:
Submit as many cases as you like
Enjoy fast sympathetic peer review and rapid publication of accepted articles
Access all the published articles
Re-use any of the published material for personal use and teaching without further permission
For information on Institutional Fellowships contact consortiasales@bmjgroup.com
Visit casereports.bmj.com for more articles like this and to become a Fellow